Overview

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if rosiglitazone, a medicine used to treat diabetes, improves response to anti-viral treatment.
Phase:
N/A
Details
Lead Sponsor:
Brooke Army Medical Center
Collaborator:
The Geneva Foundation
Treatments:
Pioglitazone